National Institute of Mental Health and Neurosciences (NIMHANS), Bangalore, India.
Schizophrenia Research Foundation (SCARF), Chennai, India.
Schizophr Res. 2021 May;231:90-97. doi: 10.1016/j.schres.2021.03.021. Epub 2021 Apr 5.
The efficacy of antipsychotic medications in the treatment of negative symptoms of schizophrenia is modest at best. Preliminary studies suggest the beneficial effects of add on Yoga, a traditional Indian practice, in the treatment of schizophrenia. Hence, in this study, we examined the efficacy of yoga as an add-on treatment for negative symptoms of schizophrenia in a randomized, wait-list controlled design from two clinical institutes in south India. 89 patients (age - 34.20 ± 8.06 years; education - 14.22 ± 2.69 years; 28 females) were randomized into the add-on yoga or treatment as usual (TAU - wait-list control) group. Patients had a mean illness duration of 10.97 ± 7.24 years with an age at onset of 23.34 ± 5.81 years. Central block randomization was followed to ensure concealed allocation. Participants randomized to the yoga treatment group attended 12 supervised yoga training sessions over two weeks and practiced yoga sessions at home for the subsequent 10 weeks. 64 patients completed the trial. An intent to treat analysis was conducted with 89 participants using a linear mixed model. Improvement in negative symptoms was our primary outcome measure. The two groups were matched on demographic variables and baseline psychopathology severity. Participants in the add-on yoga group had significantly greater improvement in negative symptoms (SANS baseline: 49.13 ± 2.30; 12-weeks follow up: 31.55 ± 2.53) compared to the TAU group (SANS baseline: 51.22 ± 2.40; 12-weeks follow up: 45.30 ± 2.93; t = 3.36; p = 0.006; Cohen's d-0.65). The current study findings suggest the efficacy of yoga as an add-on treatment for negative symptoms of schizophrenia. The effectiveness of yoga practice as a regular clinical intervention for patients needs to be explored in future studies by integrating yoga services along with other clinical services.
抗精神病药物治疗精神分裂症阴性症状的疗效充其量只是适度的。初步研究表明,印度传统瑜伽练习附加治疗对精神分裂症有益。因此,本研究采用随机、等待名单对照设计,在印度南部的两家临床机构中,考察了瑜伽附加治疗对精神分裂症阴性症状的疗效。89 名患者(年龄 34.20±8.06 岁;教育年限 14.22±2.69 年;28 名女性)被随机分为附加瑜伽或常规治疗(等待名单对照,TAU)组。患者的平均病程为 10.97±7.24 年,发病年龄为 23.34±5.81 岁。采用中央区随机化确保了隐藏的分配。随机分配至瑜伽治疗组的患者接受了为期两周的 12 次监督瑜伽训练,并在随后的 10 周内在家进行瑜伽练习。64 名患者完成了试验。采用线性混合模型对 89 名参与者进行意向治疗分析。阴性症状的改善是我们的主要结局指标。两组在人口统计学变量和基线精神病严重程度上相匹配。附加瑜伽组的患者在阴性症状方面有显著的改善(SANS 基线:49.13±2.30;12 周随访:31.55±2.53),而 TAU 组则没有(SANS 基线:51.22±2.40;12 周随访:45.30±2.93;t=3.36;p=0.006;Cohen's d=-0.65)。本研究结果表明,瑜伽作为精神分裂症阴性症状的附加治疗是有效的。未来的研究需要通过整合瑜伽服务和其他临床服务,探索瑜伽练习作为常规临床干预对患者的有效性。